| 摘要 |
<p>Disclosed is a medicament for administration to a mammal to reduce NMDA receptor-mediated neuronal damage; the medicament comprises a compound of the formula shown in Fig. 1, wherein R1 includes an amino group and R2-R17 are independently H or a short chain aliphatic group comprising 1-5 carbons, or a physiologically-acceptable salt thereof, in a concentration effective to cause such reduction.</p> |
